美 머크 경구용 치료제, 효능 50%→30% 하향 조정
An experimental COVID-19 treatment pill developed by Merck is significantly less effective than earlier data suggested.
The U.S. drugmaker said its oral pill showed a 30 percent reduction in deaths and hospitalizations based on its updated analysis while its previous data claimed a 50 percent reduction.
Merck released the data before the U.S. Food and Drug Administration published a set of documents on Friday.
And, the FDA's committee comprised of outside experts will meet on Tuesday to discuss whether to authorize the pill.
Merck's shares dropped by almost three-point-eight percent on Friday.
#Merck #COVID19pill #efficacy
📣 Arirang News(Facebook) : [ Ссылка ]
📣 Arirang News(Twitter) : [ Ссылка ]
📣 News Center(YouTube) : [ Ссылка ]
2021-11-27, 18:00 (KST)
